Professional Documents
Culture Documents
Jurnal
Jurnal
Jurnal
email: Zahrahsafira12@gmail.com
Abstract
Background: Schizophrenia is a severe mental disorder that often occurs in the
world. Current treatments for schizophrenia are typical antipsychotics and
atypical antipsychotics. Typical antipsychotics such as haloperidol,
chlorpromazine, sulpirid, and thioridazine, and atypical antipsychotics such as
risperidone, and atypical antipsychotics such as risperidone, clozapine,
olanzapine and zipracidone. In the long term use of the drug can cause
extrapyramidal symptoms, metabolic disorders such as increased blood glucose
levels.
Objective: To determine differences in blood glucose levels in schizophrenic
patients using haloperidol and risperidone at the mental hospital. Prof. Dr. M.
Ildrem Medan which took from September to December 2019.
Method: This study is a non-paired numerical analytic study with a non-
probability sampling technique that was carried out using a blood sugar level
check tool during easy touch. The number of samples used was 46 schizophrenic
patients, of which 23 people took the drug haloperidol, and 23 people took the
drug risperidone. Then performed an analysis with the Mann-Whitney test.
Results: The Mann-Whitney test results showed that there were significant
differences between the use of haloperidol and risperidone drugs in schizophrenic
patients with a P value of 0.001 (p <0.05). Risperidone drug use is higher risk
compared with haloperidol drugs.
Conclusion: The use of risperidone has a significant difference with haloperidol
on blood glucose levels when in schizophrenia patients.
Keywords: Schizophrenia, Differences in blood glucose levels at the time,
Haloperidol, and Risperidone.